Stock Events

Stock Events

Emerging World Pharma 

$0.000100
2
+$0.00+0%Wednesday 20:00

Statistics

Day High
0.000001
Day Low
0.000001
52W High
0.0001
52W Low
0.000001
Volume
6
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap158.45B
Pfizer is a major player in the pharmaceutical industry, directly competing in multiple markets that Emerging World Pharma targets, especially in developing regions.
Johnson & Johnson
JNJ
Mkt Cap617.01B
Johnson & Johnson offers a broad range of pharmaceutical products that compete with EWPI's offerings, particularly in the areas of medical devices and healthcare.
Merck
MRK
Mkt Cap356.01B
Merck operates globally in the pharmaceutical sector, offering innovative medicines that are in direct competition with EWPI's product lines.
GSK
GSK
Mkt Cap94.23B
GlaxoSmithKline focuses on a wide array of pharmaceutical products, including vaccines and major drugs that serve similar markets as EWPI.
Novartis
NVS
Mkt Cap268B
Novartis is known for its extensive research and development in pharmaceuticals, competing closely with EWPI in emerging markets.
Abbvie
ABBV
Mkt Cap464.43B
AbbVie competes in the pharmaceutical industry by providing advanced therapies, directly challenging EWPI's market share.
Sanofi
SNY
Mkt Cap95.65B
Sanofi operates globally, offering pharmaceutical solutions that compete across several of EWPI's key strategic areas, including chronic diseases.
Bristol-Myers Squibb
BMY
Mkt Cap124.91B
Bristol-Myers Squibb's broad range of pharmaceutical products competes with EWPI, especially in oncology and cardiovascular drugs.
Astrazeneca
AZN
Mkt Cap243.34B
AstraZeneca is a competitor due to its strong presence in pharmaceutical markets where EWPI is also trying to expand, particularly in emerging economies.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap46.1B
Teva Pharmaceutical Industries is a key competitor in generic and specialty medicines, areas where EWPI is also actively involved.

About

Emerging World Pharma, Inc. dedicates its resources to pharmaceutical enterprises that produce generic medications, specifically those operating within developing economies. The firm provides these companies with crucial manufacturing infrastructure, manages the hiring and skill-building of local personnel, and supplies necessary raw components. Their investment strategy is concentrated on pharmaceutical businesses that have secured agreements with religious organizations, various non-governmental groups, governmental bodies, and wholesale distributors. The company, established in 1997 with its base in Sunyani, Ghana, underwent a name change from Tubearoo, Inc. to Emerging World Pharma, Inc. in November 2009.
Show More
CEO
Terry Agrivos
Country
United States
ISIN
US29102A1034

Listings

OTC Link
US
EWPI

0 Comments

Share your thoughts

FAQs

What is Emerging World Pharma stock price today?▼
The current price of EWPI is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Emerging World Pharma stock price performance more closely on the chart.
What is Emerging World Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Emerging World Pharma stocks are traded under the ticker EWPI.
Is Emerging World Pharma stock price growing?▼
EWPI stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Emerging World Pharma has showed a +0% increase.
In which sector is Emerging World Pharma located?▼
Emerging World Pharma operates in the Health & Wellness sector.
When did Emerging World Pharma complete a stock split?▼
The last stock split for Emerging World Pharma was on October 27, 2006 with a ratio of 1:50.
Where is Emerging World Pharma headquartered?▼
Emerging World Pharma is headquartered in Sunyani, United States.